DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Acquired by Comerica Bank

Comerica Bank increased its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 41.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 225,080 shares of the medical instruments supplier's stock after acquiring an additional 65,709 shares during the quarter. Comerica Bank owned approximately 0.11% of DENTSPLY SIRONA worth $4,272,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Nordea Investment Management AB increased its stake in DENTSPLY SIRONA by 245.0% in the fourth quarter. Nordea Investment Management AB now owns 251,556 shares of the medical instruments supplier's stock valued at $4,754,000 after purchasing an additional 178,639 shares during the period. Bank of New York Mellon Corp increased its position in DENTSPLY SIRONA by 27.9% in the 4th quarter. Bank of New York Mellon Corp now owns 2,403,110 shares of the medical instruments supplier's stock valued at $45,611,000 after acquiring an additional 523,692 shares during the period. Charles Schwab Investment Management Inc. increased its position in DENTSPLY SIRONA by 1.7% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,101,133 shares of the medical instruments supplier's stock valued at $39,880,000 after acquiring an additional 35,360 shares during the period. Barclays PLC raised its stake in DENTSPLY SIRONA by 21.8% during the 3rd quarter. Barclays PLC now owns 306,809 shares of the medical instruments supplier's stock valued at $8,301,000 after acquiring an additional 54,920 shares during the last quarter. Finally, Canvas Wealth Advisors LLC lifted its position in DENTSPLY SIRONA by 126.5% during the 4th quarter. Canvas Wealth Advisors LLC now owns 326,298 shares of the medical instruments supplier's stock worth $6,245,000 after acquiring an additional 182,234 shares during the period. Hedge funds and other institutional investors own 95.70% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the company. Needham & Company LLC restated a "hold" rating on shares of DENTSPLY SIRONA in a research note on Thursday, March 13th. Wells Fargo & Company reduced their target price on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating for the company in a research note on Friday, February 28th. StockNews.com lowered shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research note on Friday, February 28th. Robert W. Baird reduced their price objective on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating for the company in a research report on Friday, February 28th. Finally, Mizuho dropped their target price on DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating on the stock in a research report on Thursday, March 13th. Thirteen analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $21.25.

Insider Transactions at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier acquired 15,142 shares of the company's stock in a transaction that occurred on Monday, March 3rd. The stock was purchased at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the transaction, the director now owns 81,971 shares in the company, valued at $1,353,341.21. This trade represents a 22.66 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders own 0.52% of the company's stock.

DENTSPLY SIRONA Trading Down 1.7 %

Shares of XRAY stock opened at $13.84 on Tuesday. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The stock has a market cap of $2.76 billion, a P/E ratio of -6.69, a P/E/G ratio of 1.80 and a beta of 0.92. The business has a fifty day simple moving average of $14.49 and a 200-day simple moving average of $17.80. DENTSPLY SIRONA Inc. has a fifty-two week low of $12.16 and a fifty-two week high of $29.13.

DENTSPLY SIRONA Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, April 11th. Investors of record on Friday, March 28th were paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 4.62%. The ex-dividend date of this dividend was Friday, March 28th. DENTSPLY SIRONA's payout ratio is currently -14.07%.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.